Full Product Details
Author: Alain Vertes (NxR Biotechnologies GmbH, Basel, Switzerland) ,
Nathan J. Dowden (Senior Vice President, Corporate Development, Rubius Therapeutics) ,
Devyn Smith (Head of Operations and Strategy, Medicinal Sciences Division of R&D, Pfizer Inc.) ,
Nasib Qureshi (National Center for Agricultural Utilization Research, US Department of Agriculture, Peoria, IL USA)
Publisher: Elsevier Science Publishing Co Inc
Imprint: Academic Press Inc
Weight: 2.040kg
ISBN: 9780128120347
ISBN 10: 0128120347
Pages: 846
Publication Date: 10 February 2020
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Active
Availability: Not yet available
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.
Author Information
University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flanders-Artois* Sloan Fellow from London Business School and a microbiologist by training (University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flandres-Artois). * Consulting, Partnering & Fund Raising, Founder, Managing Director, NxR Biotechnologies, Switzerland.* Dr. Vertes is a strategy and business development consultant for cell therapeutic biotech companies, and works to enable seed funding in the field. Focusing on technology deployment and innovation commercialization, he has contributed to both industrial and pharmaceutical biotechnology, in different functions including research, manufacturing, contract research, and strategic alliances in pharmaceuticals (Lilly, Pfizer, Roche). * Championed radical innovation for bringing to patients disease-modifying, paradigm-changing therapeutics such as siRNA, and led in a scientific and business manner Roche's global cell therapeutics strategy and implementation team resulting in Roche's entry in 2010 in the field of regenerative medicine.* Member, Industry Committee-Europe, Tissue Engineering and Regenerative Medicine International Society* Co-Editor, Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies (Wiley, 2015). * Head of Operations & Strategy, Medicinal Sciences Division of R&D, Pfizer Inc.* Responsible for all cell & gene therapy products, as well as previously developing Pfizer's Regenerative Medicine program.* PhD in Genetics from Harvard Medical School.* Adjunct faculty member at Northeastern University. US Department of Agriculture, National Center for Agricultural Utilization Research, Bioenergy Research Unit, Peoria, IL US US Department of Agriculture, National Center for Agricultural Utilization Research, Peoria, IL US * Senior Researcher/Senior Scientist, United States Department of Agriculture, National Center for Agricultural Utilization Research, Bioenergy Research Unit. * Affiliate Faculty, Institute for Genomic Biology, Univ. of Illinois. * Adjunct Professor (Biochemical Engineering), University of Illinois. * EIC, World Journal of Microbiology & Biotechnology (Springer). * Co-Editor, Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies (Wiley, 2015).
